Spots Global Cancer Trial Database for chiauranib
Every month we try and update this database with for chiauranib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer | NCT03216343 | Small Cell Lung... | Chiauranib | 18 Years - 75 Years | Chipscreen Biosciences, Ltd. | |
| Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer | NCT04830813 | Small Cell Lung... | Chiauranib Placebo | 18 Years - 75 Years | Chipscreen Biosciences, Ltd. | |
| Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma | NCT03974243 | Non-hodgkin's L... | Chiauranib Chidamide | 18 Years - 70 Years | Chipscreen Biosciences, Ltd. | |
| Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. | NCT05271292 | Small Cell Lung... Advanced Solid ... | Chiauranib | 18 Years - | Chipscreen Biosciences, Ltd. | |
| Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. | NCT05271292 | Small Cell Lung... Advanced Solid ... | Chiauranib | 18 Years - | Chipscreen Biosciences, Ltd. | |
| Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer | NCT03216343 | Small Cell Lung... | Chiauranib | 18 Years - 75 Years | Chipscreen Biosciences, Ltd. | |
| Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS) | NCT05497843 | Soft Tissue Sar... | Chiauranib | 18 Years - 75 Years | Chipscreen Biosciences, Ltd. | |
| Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma | NCT03974243 | Non-hodgkin's L... | Chiauranib Chidamide | 18 Years - 70 Years | Chipscreen Biosciences, Ltd. | |
| Phase Ib Study of Chiauranib in Patients With Ovarian Cancer | NCT03166891 | Ovarian Cancer | Chiauranib | 18 Years - 70 Years | Chipscreen Biosciences, Ltd. | |
| Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer | NCT04830813 | Small Cell Lung... | Chiauranib Placebo | 18 Years - 75 Years | Chipscreen Biosciences, Ltd. | |
| Mass Balance Study of [14C]Chiauranib | NCT05371899 | Small Cell Lung... | Chiauranib | 18 Years - 75 Years | Chipscreen Biosciences, Ltd. | |
| Chiauranib Plus Weekly Paclitaxel in Patients With Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer | NCT04921527 | Ovarian Cancer Relapsed or Ref... Chiauranib Paclitaxel | chiauranib Placebo Paclitaxel | 18 Years - 70 Years | Chipscreen Biosciences, Ltd. | |
| Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS) | NCT05497843 | Soft Tissue Sar... | Chiauranib | 18 Years - 75 Years | Chipscreen Biosciences, Ltd. | |
| Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer | NCT03901118 | Ovarian Cancer | chiauranib etoposide paclitaxel | 18 Years - 70 Years | Chipscreen Biosciences, Ltd. | |
| Phase I Study of Chiauranib in Patients With Advanced Solid Tumors | NCT02122809 | Solid Tumors | Chiauranib | 18 Years - 65 Years | Chipscreen Biosciences, Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
